This topic contains a solution. Click here to go to the answer

Author Question: What do the non-representative samples that are inherent to clinical trials suggest? a) The ... (Read 72 times)

anshika

  • Hero Member
  • *****
  • Posts: 510
What do the non-representative samples that are inherent to clinical trials suggest?
 
  a) The treatment method used in any given study may not be equally therapeutic to all participants
  b) Prevalence rates of many disorders may be incorrect
  c) Community treatment orders are ineffective
  d) It is risky to generalize from controlled studies to the actual population

Question 2

Jamal is seeking treatment for combat-related PTSD. If his experience is much like others, he will receive:
 
  a) Exposure based treatment
  b) Empirically supported treatment
  c) Whatever treatment his therapist is most comfortable delivering
  d) No treatment, as the military denies the existence of PTSD



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Cheesycrackers

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

d

Answer to Question 2

c




anshika

  • Member
  • Posts: 510
Reply 2 on: Jun 22, 2018
Excellent


anyusername12131

  • Member
  • Posts: 327
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library